StockData
Curanex Pharmaceuticals Inc logo

Curanex Pharmaceuticals Inc (CURX) stock

CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70+0.07 (+1.40%)

Close on Nov 17, 2026Market cap $7.37MP/E –Yield –

Curanex Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Curanex Pharmaceuticals's total assets was $3.10M at Sep 30, 2026. For fiscal 2025 it was $11.58M, up 2135.8% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.58M+2135.8%
FY2024Dec 31, 2024$517.94K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.10M-78.6%
Q2 FY2026Jun 30, 2026$5.07M+544.6%
Q1 FY2026Mar 31, 2026$8.41M+1524.0%
Q4 FY2025Dec 31, 2025$11.58M–
Q3 FY2025Sep 30, 2025$14.48M–
Q2 FY2025Jun 30, 2025$787.17K–
Q4 FY2024Dec 31, 2024$517.94K–

More Curanex Pharmaceuticals figures

See a number that looks wrong?